Flavonoids are among the most structurally diverse families of plant compounds identified to date, with over 6,000 individual members catalogued. They are classified into several subclasses , flavonols, flavones, flavanones, isoflavones, anthocyanins, and flavan-3-ols (catechins), among others , distinguished by the oxidation state and substitution pattern of their central heterocyclic ring (the C-ring).
Plants produce flavonoids through the phenylpropanoid biosynthetic pathway, using phenylalanine as the primary precursor. Functionally within the plant, these compounds serve roles in ultraviolet light attenuation, pigmentation (particularly the blues, reds, and purples of flower petals and fruit skins), signalling during root–microbe symbiosis, and defence against herbivory and pathogens.
From a phytochemical standpoint, flavonoids are of active research interest due to their capacity to interact with a range of biological targets in vitro, including free-radical scavenging, metal ion chelation, and modulation of various enzyme systems. Peer-reviewed literature exploring these interactions is substantial, though researchers consistently note that bioavailability following oral ingestion varies considerably across subclasses and individuals, and that in vitro findings do not automatically translate to in vivo outcomes in humans. No flavonoid-containing substance or extract is approved by the Therapeutic Goods Administration (TGA) as a standalone therapeutic agent for any specific condition without meeting the evidentiary standards of the Australian Register of Therapeutic Goods (ARTG).
Dietary sources include vegetables, legumes, tea, cocoa, and many culinary herbs. Within the herbal and complementary medicine sector in Australia, flavonoid-containing plant extracts may appear in listed or registered products on the ARTG; such listings require evidence of quality and safety, but do not represent TGA endorsement of efficacy claims beyond those permitted under the listed medicines framework.
Sources: